"IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ"

Summary

A prospective, open-label, uncontrolled, non-randomized, single-center Phase I/II clinical trial evaluating the safety of Anakinra in the immediate post-transplant period following pancreatic transplantation

Timeline

Start

2026-05-01

Primary completion

2028-11-01

Completion

2029-11-01

Drugs

Indications